468 related articles for article (PubMed ID: 8843456)
1. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
2. Proliferative verrucous leukoplakia: a follow-up study of 54 cases.
Silverman S; Gorsky M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):154-7. PubMed ID: 9269017
[TBL] [Abstract][Full Text] [Related]
3. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts are an infrequent finding in the microenvironment of proliferative verrucous leukoplakia-associated squamous cell carcinoma.
Akrish SJ; Rachmiel A; Sabo E; Vered M; Ben-Izhak O
J Oral Pathol Med; 2017 May; 46(5):353-358. PubMed ID: 27681951
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy.
Shirasuna K; Hayashido Y; Sugiyama M; Yoshioka H; Matsuya T
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):349-53. PubMed ID: 2024456
[TBL] [Abstract][Full Text] [Related]
7. Proliferative verrucous leukoplakia: a report of ten cases.
Zakrzewska JM; Lopes V; Speight P; Hopper C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):396-401. PubMed ID: 8899776
[TBL] [Abstract][Full Text] [Related]
8. [To the question of proliferative verrucous leukoplakia malignant potential].
Ivina AA; Semkin VA; Rabinovich OF; Babichenko II
Arkh Patol; 2020; 82(3):13-17. PubMed ID: 32593261
[TBL] [Abstract][Full Text] [Related]
9. Proliferative verrucous leukoplakia. Four cases with flow cytometric analysis.
Kahn MA; Dockter ME; Hermann-Petrin JM
Oral Surg Oral Med Oral Pathol; 1994 Oct; 78(4):469-75. PubMed ID: 7800379
[TBL] [Abstract][Full Text] [Related]
10. 7 Cases of Proliferative Verrucous Leukoplakia: The Need for a High Clinical Suspicion Among Dental Practitioners.
Owosho AA; Bilodeau EA; Summersgill KF
Pa Dent J (Harrisb); 2015; 82(1):26-31. PubMed ID: 26299096
[TBL] [Abstract][Full Text] [Related]
11. Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma--a clinical, histologic and immunohistochemical study.
Akrish S; Ben-Izhak O; Sabo E; Rachmiel A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Mar; 119(3):318-25. PubMed ID: 25547823
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
14. Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma.
Lombardi N; Varoni EM; Franchini R; Lodi G
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967933
[TBL] [Abstract][Full Text] [Related]
15. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Study of TGF-β1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma: Correlations Between Clinicopathologic Factors and Overall Survival.
Wagner VP; Cardoso PR; Dos Santos JN; Meurer L; Vargas PA; Fonseca FP; Carrard VC; Martins MD
Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):651-659. PubMed ID: 26990749
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
[TBL] [Abstract][Full Text] [Related]
19. Proliferative verrucous leukoplakia: a concise update.
Bagan J; Scully C; Jimenez Y; Martorell M
Oral Dis; 2010 May; 16(4):328-32. PubMed ID: 20233330
[TBL] [Abstract][Full Text] [Related]
20. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
Gandolfo S; Castellani R; Pentenero M
J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
